Effect of microbial dysbiosis on autoimmune associated inflammation
International Review of Cell and Molecular Biology · 2025
DOI: 10.1016/bs.ircmb.2024.12.016 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2025. Verfasst von Kamini Singh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Lymphoma/Myloma, MD Anderson Cancer Centre, Houston, TX, United States. Hauptthemen laut MEDLINE: Dysbiosis, Autoimmune Diseases, Inflammation, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 104 Literaturangaben.
Abstract (Originalsprache)
Trillions of microorganisms inhabit the human body, playing crucial roles in the development of the immune system, maintaining balance within the gut's immune system, and overall well-being. When these microbial communities experience imbalance, known as dysbiosis, it can lead to localized inflammatory conditions such as colitis and inflammatory bowel diseases, as well as systemic autoimmune disorders like type 1 diabetes, rheumatoid arthritis, and multiple sclerosis. Gut microbes engage with the immune system through various means, including influencing host microRNAs to regulate gene expression and generating metabolites that interact with cellular receptors such as TLRs and GPCRs. These interactions impact critical immune processes like the differentiation of lymphocytes, the production of interleukins, and the maintenance of gut barrier function. Looking into, how gut microbes contribute to or defend against systemic autoimmune diseases is crucial for developing strategies to manage or prevent these conditions. These approaches may include dietary or lifestyle modifications, microbiome-targeted therapies such as prebiotics or probiotics, the identification of diagnostic biomarkers for predicting disease risk, and monitoring and intervening in shifts in microbial populations during autoimmune flare-ups. Recognizing the microbiome's significance in systemic autoimmune diseases offers promise for transforming these presently challenging-to-treat conditions into more controllable or preventable ones.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Lymphoma/Myloma, MD Anderson Cancer Centre, Houston, TX, United States.
- Department of Zoology, Shankarlal Agrawal Science College, Salekasa, Gondia, Maharashtra, India. Electronic address: bhadauriya.amar@gmail.com.
Zitieren
APA
Singh, K., & Bhadauriya, A. S. (2025). Effect of microbial dysbiosis on autoimmune associated inflammation. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2024.12.016
Vancouver
Singh K, Bhadauriya AS. Effect of microbial dysbiosis on autoimmune associated inflammation. International Review of Cell and Molecular Biology. 2025. doi:10.1016/bs.ircmb.2024.12.016
BibTeX
@article{Singh2025,
author = {Singh, Kamini and Bhadauriya, Amarpal Singh},
title = {Effect of microbial dysbiosis on autoimmune associated inflammation},
journal = {International Review of Cell and Molecular Biology},
year = {2025},
doi = {10.1016/bs.ircmb.2024.12.016}
}
EUVIMED